The Trout Group to Host Trout Talk With Louis Weiner, M.D., of Georgetown Lombardi Comprehensive Cancer Center
February 22, 2016
NEW YORK, NY -- (Marketwired) -- 02/22/16 -- The Trout Group, the leading global investor relations and strategic advisory firm servicing the life sciences industry, today announced an upcoming Trout Talk key opinion leader (KOL) discussion featuring Louis Weiner, M.D., Director of the Georgetown Lombardi Comprehensive Cancer Center. Dr. Lombardi's talk, Antibody Therapy of Cancer: The Revolution Continues, will focus on antibodies to watch in 2016. The Trout Talk will be webcast live on February 23 at 1 pm ET and can be accessed at trouttalk.troutgroup.com.
Trout Talks is an ongoing series featuring conversations with prominent and up-and-coming researchers who are driving scientific innovation forward.
Dr. Weiner is an internationally recognized medical oncologist specializing in the treatment of gastrointestinal cancers. He serves on the board of the Antibody Society, and is a co-founder of Jounce Therapeutics. An accomplished researcher developing novel immunotherapy treatments for cancer, Dr. Weiner is widely known for his work in antibody-based therapeutics, including the development of bi-specifics.
Recent publications include:
- Mechanisms of Action of Therapeutic Antibodies for Cancer. Weiner LM, et al.
Mol Immunol. 2015 Oct
- Cancer Immunology for the Clinician. Weiner LM. Clin Adv Hematol Oncol. 2015 May.
- Beyond Peptides and mAbs -- Current Status and Future Perspectives for Bio-therapeutics with Novel Constructs. Weiner LM, et al. J Clin Pharmacol. 2015 Mar.
- The Development of Immune-Conjugates for Targeted Cancer Therapy. Weiner LM, et al.
Nat Rev Clin Oncol. 2014
The Trout Talk, moderated by Trout Group scientific advisor Neil Canavan, will consist of a 1 hour presentation by Dr. Weiner followed by up to 30 minutes of questions from webcast participants. Questions should be sent to email@example.com at any time before or during the event; submitted questions will be answered in the order received, and the asker's identity shall remain anonymous.
About The Trout Group:
The Trout Group is a global investor relations and strategic advisory firm. Since 1996, Trout has been a leading strategic partner to the life sciences industry, connecting companies, the capital markets and innovations in the sector. Trout's unique suite of services at the intersection of scientific advances and a network of institutional relationships creates long term value for stakeholders.
For general inquires please contact:
Source: The Trout Group LLC